Glass is in Session by Clarus
Ask any pet owner and they will say that their pet is a part of their family. Unwavering love and loyalty create a bond between humans and their animal friends that is hard to measure. Naturally, when injuries occur, people turn to a place where their pet can receive as high-quality of care as…
Latest
AEC
How We Made Manufacturing More Environmentally Friendly
It is one thing for a company to be an innovator with the products it is developing, but it is another thing to be an innovator and trendsetter in sustainability. Clarus is a company that has strived for and excelled in both. On today’s episode of Glass is in Session, we sat back down…
AEC
Why Do A&D Customers Care About Sustainability? with Ben Kraft of Clarus
On today’s episode of Glass is in Session, we brought Ben Kraft, also known as the ‘Glass Man Extraordinaire,’ into the studio. Kraft, an A&D sales representative for Clarus, gives his sales and manufacturing insight on the reasons for and the impacts of green design on company-client relationships. Kraft helps answer these questions as…
AEC
How to Make the Most of KBIS 2019
The Kitchen & Bath Industry Show (KBIS) hits Las Vegas from Feb. 19-21 as North America’s largest trade show focused solely on all aspects of kitchen and bath design. Over 31,000 attendees are expected this year with more than 600 exhibitors showing off their latest innovative designs. This show brings stakeholders and industry leaders together…
AEC
How Clarus Avoids Greenwashing, and Why You Should Too with Karen Righthand of SCS Global Services
Consumers today are extremely conscious about what kinds of products they’re purchasing for their bodies, homes, and businesses, and with so many choices available it’s hard to know what products may be guilty of some of the “Seven Sins of Greenwashing” — otherwise known as stating a product is generally natural, green friendly, or…
AEC
Fixed, Flexible, and Gliding Over All with Brittney Ricks of Clarus
With Glass is in Session, we’ve focused a lot on the innovative design that Clarus has brought to the glassboard industry, and in many regards, the path that they’ve paved for glassboards in general. Our past several episodes have been with Vice President of Brand & Marketing, Brittney Ricks, as she’s broken down the product…
AEC
Clarus Expands into European Markets at ORGATEC 2019
Our Europe team offers the most custom glassboard solutions on the market! From our first glassboard Float, to innovative solutions like Flip, View, and Glide – Clarus glassboards provide the best writing surface available. To learn more, visit our products page: https://www.clarus.com/products/
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…